Rigel Pharmaceuticals RIGL
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2026Q1 | 27.04 | 400 | 2.19 | 9 | 1.7 | 505 |
| 2025Q4 | 42.83 | 391 | 105.31 | 268 | 70.9 | 514 |
| 2025Q3 | 28.33 | 118 | 27.96 | 28 | 12.42 | 243 |
| 2025Q2 | 18.73 | 82 | 118.63 | 60 | 31.15 | 207 |
| 2025Q1 | 17.99 | 19 | 104.74 | 11 | 6.73 | 176 |
| 2024Q4 | 16.82 | 3 | 14 | 9.45 | 164 | |
| 2024Q3 | 16.18 | -15 | 12 | 9.28 | 139 | |
| 2024Q2 | 8.22 | -30 | -1 | -0.81 | 128 | |
| 2024Q1 | 14.8 | -32 | -8 | -6.77 | 127 | |
| 2023Q4 | 14.5 | -29 | 1 | 0.63 | 117 | |
| 2023Q3 | 10.8 | -32 | -6 | -4.9 | 115 | |
| 2023Q2 | 12.9 | -28 | -7 | -5.48 | 117 | |
| 2023Q1 | 13.2 | -24 | -14 | -10.5 | 124 | |
| 2022Q4 | 15 | -14 | 1 | 1.12 | 134 | |
| 2022Q3 | 11.8 | -20 | -19 | -15.63 | 116 | |
| 2022Q2 | 11.3 | -4 | -13 | -9.74 | 128 | |
| 2022Q1 | 29.9 | 7 | -147.66 | -27 | -17.35 | 149 |
| 2021Q4 | 26.5 | 30 | -56.57 | -23 | -12.8 | 167 |
| 2021Q3 | 36.3 | 50 | -35.58 | -21 | -10.8 | 187 |
| 2021Q2 | 43.4 | 68 | -18.88 | -14 | -6.62 | 202 |